Miriam Zuñiga-Eulogio

Ms. Miriam Zuñiga-Eulogio

Laboratorio de Biología Celular del Cáncer, Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Guerrero. Av. Lázaro Cárdenas s/n, C.P. 39087, Chilpancingo de los Bravo Gro. MEX
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MOMonserrat Olea-Flores
Monserrat Olea-Flores
MZMiriam Zuñiga-Eulogio
Miriam Zuñiga-Eulogio
Miguel Mendoza-CatalánMiguel Mendoza-Catalán
Miguel Mendoza-Catalán
HRHugo Alberto Rodríguez Ruiz
Hugo Alberto Rodríguez Ruiz
ECEduardo Castañeda-Saucedo
Eduardo Castañeda-Saucedo
Napoleón Navarro-TitoNapoleón Navarro-Tito
Napoleón Navarro-Tito
Epithelial–mesenchymal transition (EMT) is a reversible cellular process, characterized by changes in gene expression and activation of proteins, favoring the trans-differentiation of the epithelial phenotype to a mesenchymal phenotype. This process increases cell migration and invasion of tumor cells, progression of the cell cycle, and resistance to apoptosis and chemotherapy, all of which support tumor progression. One of the signaling pathways involved in tumor progression is the MAPK pathway. Within this family, the ERK subfamily of proteins is known for its contributions to EMT. The ERK subfamily is divided into typical (ERK 1/2/5), and atypical (ERK 3/4/7/8) members. These kinases are overexpressed and hyperactive in various types of cancer. They regulate diverse cellular processes such as proliferation, migration, metastasis, resistance to chemotherapy, and EMT. In this context, in vitro and in vivo assays, as well as studies in human patients, have shown that ERK favors the expression, function, and subcellular relocalization of various proteins that regulate EMT, thus promoting tumor progression. In this review, we discuss the mechanistic roles of the ERK subfamily members in EMT and tumor progression in diverse biological systems.

1 November 2019 in Endocrine Connections
Verified
Journal Article
Open access
PDF file
JJJuan Carlos Juárez-Cruz
Juan Carlos Juárez-Cruz
MZMiriam Zuñiga-Eulogio
Miriam Zuñiga-Eulogio
MOMonserrat Olea-Flores
Monserrat Olea-Flores
ECEduardo Castañeda-Saucedo
Eduardo Castañeda-Saucedo
Miguel Mendoza-CatalánMiguel Mendoza-Catalán
Miguel Mendoza-Catalán
Napoleón Navarro-TitoNapoleón Navarro-Tito
Napoleón Navarro-Tito
Breast cancer is the most common invasive neoplasia, and the second leading cause of the cancer deaths in women worldwide. Mammary tumorigenesis is severely linked to obesity, one potential connection is leptin. Leptin is a hormone secreted by adipocytes, which contributes to the progression of breast cancer. Cell migration, metalloproteases secretion, and invasion are cellular processes associated with various stages of metastasis. These processes are regulated by the kinases FAK and Src. In this study, we utilized the breast cancer cell lines MCF7 and MDA-MB-231 to determine the effect of leptin on FAK and Src kinases activation, cell migration, metalloprotease secretion, and invasion. We found that leptin activates FAK and Src and induces the localization of FAK to the focal adhesions. Interestingly, leptin promotes the activation of FAK through a Src- and STAT3-dependent canonical pathway. Specific inhibitors of FAK, Src and STAT3 showed that the effect exerted by leptin in cell migration in breast cancer cells is dependent on these proteins. Moreover, we established that leptin promotes the secretion of the extracellular matrix remodelers, MMP-2 and MMP-9 and invasion in a FAK and Src-dependent manner. Our findings strongly suggest that leptin promotes the development of a more aggressive invasive phenotype in mammary cancer cells.

15 March 2021 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
LSLorena Cayetano Salazar
Lorena Cayetano Salazar
MOMonserrat Olea-Flores
Monserrat Olea-Flores
MZMiriam Zuñiga-Eulogio
Miriam Zuñiga-Eulogio
CWCaroline Weinstein‐Oppenheimer
Caroline Weinstein‐Oppenheimer
GFGloria Fernández-Tilapa
Gloria Fernández-Tilapa
Napoleón Navarro-TitoNapoleón Navarro-Tito
Napoleón Navarro-Tito

24 September 2019 in Cells
Verified
Journal Article
Open access
PDF file
MOMonserrat Olea-Flores
Monserrat Olea-Flores
MZMiriam Zuñiga-Eulogio
Miriam Zuñiga-Eulogio
ATArvey Tacuba-saavedra
Arvey Tacuba-saavedra
MBMagdalena Bueno-Salgado
Magdalena Bueno-Salgado
ASAndrea Sánchez-Carvajal
Andrea Sánchez-Carvajal
Napoleón Navarro-TitoNapoleón Navarro-Tito
Napoleón Navarro-Tito
Leptin is one of the main adipokines secreted in breast tissue. Leptin promotes epithelial–mesenchymal transition (EMT), cell migration and invasion in epithelial breast cells, leading to tumor progression. Although, the molecular mechanisms that underlie these events are not fully understood, the activation of different signaling pathways appears to be essential. In this sense, the effects of leptin on the activation of kinases like Src and FAK, which regulate signaling pathways that activate the EMT program, are not completely described. Therefore, we investigated the involvement of these kinases using an in vitro model for leptin-induced EMT process in the non-tumorigenic MCF10A cell line. To this end, MCF10A cells were stimulated with leptin, and Src and FAK activation was assessed. Specific events occurring during EMT were also evaluated in the presence or absence of the kinases’ chemical inhibitors PP2 and PF-573228. For instance, we tested the expression and subcellular localization of the EMT-related transcription factors Twist and β-catenin, by western blot and immunofluorescence. We also evaluated the secretion and activation of matrix metalloproteases (MMP-2 and MMP-9) by gelatin zymography. Invasiveness properties of leptin-stimulated cells were determined by invadopodia formation assays, and by the Transwell chamber method. Our results showed that leptin promotes EMT through Src and FAK activation, which leads to the secretion and activation of MMP-2 and MMP-9, invadopodia formation and cell invasion in MCF10A cells. In conclusion, our data suggest that leptin promotes an increase in the expression levels of Twist and β-catenin, the secretion of MMP-2, MMP-9, the invadopodia formation and invasion in MCF10A cells in a Src and FAK-dependent manner.

15 December 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
MOMonserrat Olea-Flores
Monserrat Olea-Flores
JCJUAN CARLOS CRUZ
JUAN CARLOS CRUZ
MZMiriam Zuñiga-Eulogio
Miriam Zuñiga-Eulogio
ECErika Jaqueline Acosta De la Cruz
Erika Jaqueline Acosta De la Cruz
EGEduardo García-Rodríguez
Eduardo García-Rodríguez
Napoleón Navarro-TitoNapoleón Navarro-Tito
Napoleón Navarro-Tito
Leptin is a hormone secreted mainly by adipocytes; physiologically, it participates in the control of appetite and energy expenditure. However, it has also been linked to tumor progression in different epithelial cancers. In this review, we describe the effect of leptin on epithelial–mesenchymal transition (EMT) markers in different study models, including in vitro, in vivo, and patient studies and in various types of cancer, including breast, prostate, lung, and ovarian cancer. The different studies report that leptin promotes the expression of mesenchymal markers and a decrease in epithelial markers, in addition to promoting EMT-related processes such as cell migration and invasion and poor prognosis in patients with cancer. Finally, we report that leptin has the greatest biological relevance in EMT and tumor progression in breast, lung, prostate, esophageal, and ovarian cancer. This relationship could be due to the key role played by the enriched tumor microenvironment in adipose tissue. Together, these findings demonstrate that leptin is a key biomolecule that drives EMT and metastasis in cancer.

18 August 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
MOMonserrat Olea-Flores
Monserrat Olea-Flores
MZMiriam Zuñiga-Eulogio
Miriam Zuñiga-Eulogio
ATArvey Tacuba-saavedra
Arvey Tacuba-saavedra
MBMagdalena Bueno-Salgado
Magdalena Bueno-Salgado
ASAndrea Sánchez-Carvajal
Andrea Sánchez-Carvajal
Napoleón Navarro-TitoNapoleón Navarro-Tito
Napoleón Navarro-Tito
Leptin is one of the main adipokines secreted in breast tissue, and has been associated with epithelial-mesenchymal transition (EMT) and tumor progression in breast cancer. Leptin promotes EMT, cell migration and invasion in epithelial breast cells, leading to tumor progression. However, the molecular mechanism that underlies these events is not fully understood; however, the activation of different signaling pathways appears to be essential. In this sense, the effect of leptin on the activation of kinases like Src and FAK, which regulate signaling pathways that activate the EMT program, has not been completely described. Therefore, we investigated the involvement of these kinases using an in vitro model for leptin-induced EMT process in the non-tumorigenic MCF10A cell line. To this end, MCF10A cells were stimulated with leptin, and Src and FAK activation was assessed. Specific events occurring during EMT were also evaluated in the presence or absence of the kinases’s chemical inhibitors PP2 and PF-573228. For instance, we tested the expression and subcellular localization of the EMT-related transcription factors Twist and □-catenin, by western blot and immunofluorescence. We also evaluated the secretion and activation of matrix metalloproteases (MMP-2 and MMP-9) by gelatin zymography. Invasiveness properties of leptin-stimulated cells were determined by invadopodia formation assays, and by the transwell chamber method. Our results showed that leptin promotes EMT through Src and FAK activation, which leads to the secretion and activation of MMP-2 and MMP-9, invadopodia formation and cell invasion in MCF10A cells. In conclusion, our data suggest that leptin promotes an increase in the expression levels of Twist and □-catenin, the secretion of MMP-2, MMP-9, the invadopodia formation and invasion in MCF10A cells in a Src and FAK-dependent manner.